Sign inGet started

Ticktin Robert

Insider CIK 1613482 · EPRS General Counsel · PMVP General Counsel & COO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PMVP PMV Pharmaceuticals, Inc. A Award deriv2026-03-052026-03-09319,270— $0319,270SEC↗
PMVP PMV Pharmaceuticals, Inc. S Sale2025-07-012025-07-0323,151$1.06 $24.5K98,695SEC↗
EPRS EPIRUS Biopharmaceuticals, A Award deriv2016-05-272016-05-31230,000— $0230,000SEC↗
EPRS EPIRUS Biopharmaceuticals, M Exercise deriv2016-02-272016-03-012,134— $06,400SEC↗
EPRS EPIRUS Biopharmaceuticals, M Exercise deriv2016-02-272016-03-01949— $00SEC↗
EPRS EPIRUS Biopharmaceuticals, M Exercise2016-02-272016-03-012,134— $06,083SEC↗
EPRS EPIRUS Biopharmaceuticals, M Exercise2016-02-272016-03-01949— $03,949SEC↗
EPRS EPIRUS Biopharmaceuticals, P Buy2015-12-212015-12-223,000$3.72 $11.2K3,000SEC↗
EPRS EPIRUS Biopharmaceuticals, A Award deriv2015-11-022015-11-0339,474— $039,474SEC↗
EPRS EPIRUS Biopharmaceuticals, A Award deriv2015-02-272015-03-0265,006— $065,006SEC↗
EPRS EPIRUS Biopharmaceuticals, A Award deriv2015-02-272015-03-02949— $0949SEC↗
EPRS EPIRUS Biopharmaceuticals, A Award deriv2015-02-272015-03-028,534— $08,534SEC↗
EPRS EPIRUS Biopharmaceuticals, A Award deriv2014-07-162014-07-1799,442— $099,442SEC↗